Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|
73 | Ankara Universitesi Eczacilik Fakultesi Dergisi | journal | 0.100 Q4 | 13 | 0 | 39 | 0 | 0 | 39 | 0.00 | 0.00 | |
72 | Eurasian Journal of Analytical Chemistry (discontinued) | journal | 0.101 Q4 | 16 | 18 | 22 | 408 | 4 | 22 | 0.18 | 22.67 | |
71 | Bulletin of Pharmaceutical Sciences. Assiut | journal | 0.102 Q4 | 10 | 13 | 59 | 408 | 3 | 59 | 0.06 | 31.38 | |
70 | Journal of Pharmacy of Istanbul University | journal | 0.102 Q4 | 11 | 10 | 11 | 306 | 0 | 11 | 0.00 | 30.60 | |
69 | Advanced Pharmaceutical Bulletin | journal | 0.108 Q4 | 56 | 40 | 14 | 1073 | 3 | 14 | 0.21 | 26.83 | |
68 | Fabad Journal of Pharmaceutical Sciences | journal | 0.122 Q4 | 19 | 23 | 72 | 764 | 14 | 72 | 0.02 | 33.22 | |
67 | Frontiers in Drug Design and Discovery | book series | 0.125 Q4 | 9 | 0 | 18 | 0 | 3 | 17 | 0.00 | 0.00 | |
66 | Pharmaceutical Sciences | journal | 0.133 Q3 | 26 | 30 | 94 | 997 | 13 | 94 | 0.10 | 33.23 | |
65 | Iranian Journal of Pharmaceutical Sciences | journal | 0.136 Q3 | 16 | 24 | 66 | 560 | 17 | 66 | 0.26 | 23.33 | |
64 | Archives of Clinical Infectious Diseases | journal | 0.139 Q4 | 22 | 27 | 143 | 463 | 38 | 126 | 0.19 | 17.15 | |
63 | Iranian Journal of Medical Sciences | journal | 0.139 | 40 | 48 | 170 | 1151 | 45 | 153 | 0.22 | 23.98 | |
62 | Hacettepe University Journal of the Faculty of Pharmacy | journal | 0.143 Q3 | 9 | 12 | 36 | 655 | 9 | 36 | 0.22 | 54.58 | |
61 | Physiology and Pharmacology (Iran) | journal | 0.155 Q4 | 15 | 55 | 146 | 1907 | 37 | 146 | 0.23 | 34.67 | |
60 | Jordan Journal of Pharmaceutical Sciences | journal | 0.164 Q3 | 12 | 22 | 59 | 610 | 23 | 59 | 0.35 | 27.73 | |
59 | Iranian Journal of Basic Medical Sciences | journal | 0.166 Q4 | 57 | 84 | 119 | 2736 | 67 | 119 | 0.52 | 32.57 | |
58 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.179 Q4 | 28 | 25 | 75 | 2498 | 56 | 74 | 0.94 | 99.92 | |
57 | Turkish Journal of Pharmaceutical Sciences | journal | 0.179 Q3 | 22 | 33 | 74 | 999 | 32 | 74 | 0.37 | 30.27 | |
56 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.183 Q3 | 27 | 35 | 109 | 2441 | 66 | 98 | 0.47 | 69.74 | |
55 | Journal of Medicinal Plants | journal | 0.186 Q3 | 27 | 84 | 256 | 2762 | 105 | 256 | 0.31 | 32.88 | |
54 | Current Drug Therapy | journal | 0.187 Q3 | 20 | 36 | 97 | 2407 | 47 | 91 | 0.36 | 66.86 | |
53 | Iranian Journal of Pharmacology and Therapeutics | journal | 0.190 Q3 | 24 | 9 | 45 | 255 | 33 | 45 | 0.63 | 28.33 | |
52 | Open Drug Discovery Journal | journal | 0.199 Q4 | 10 | 0 | 26 | 0 | 18 | 23 | 0.69 | 0.00 | |
51 | Marmara Pharmaceutical Journal | journal | 0.207 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
50 | Current Enzyme Inhibition | journal | 0.221 Q3 | 19 | 12 | 68 | 1077 | 49 | 65 | 0.65 | 89.75 | |
49 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.235 Q3 | 17 | 34 | 78 | 2748 | 37 | 70 | 0.39 | 80.82 | |
48 | BioImpacts | journal | 0.243 Q3 | 47 | 27 | 35 | 1203 | 21 | 32 | 0.60 | 44.56 | |
47 | Acta Pharmaceutica Sciencia | journal | 0.273 Q2 | 23 | 0 | 129 | 0 | 102 | 129 | 0.75 | 0.00 | |
46 | Letters in Drug Design and Discovery | journal | 0.284 Q2 | 37 | 129 | 344 | 3925 | 319 | 342 | 0.93 | 30.43 | |
45 | Iranian Journal of Pharmaceutical Research | journal | 0.300 Q2 | 58 | 144 | 222 | 4151 | 201 | 210 | 0.74 | 28.83 | |
44 | Current Pharmacogenomics and Personalized Medicine | journal | 0.368 Q3 | 20 | 41 | 89 | 2194 | 140 | 72 | 1.24 | 53.51 | |
43 | Drug Metabolism Letters | journal | 0.374 Q2 | 31 | 29 | 112 | 1010 | 140 | 111 | 1.39 | 34.83 | |
42 | Current Radiopharmaceuticals | journal | 0.392 Q3 | 32 | 45 | 95 | 2173 | 99 | 86 | 1.23 | 48.29 | |
41 | Anti-Infective Agents | journal | 0.399 Q3 | 26 | 27 | 43 | 1255 | 59 | 40 | 1.22 | 46.48 | |
40 | Medicinal Chemistry | journal | 0.402 Q3 | 50 | 139 | 199 | 4664 | 317 | 197 | 1.48 | 33.55 | |
39 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.412 Q3 | 45 | 23 | 83 | 1226 | 111 | 77 | 1.38 | 53.30 | |
38 | Current Pharmaceutical Analysis | journal | 0.425 Q2 | 27 | 48 | 96 | 1591 | 147 | 95 | 1.50 | 33.15 | |
37 | Current Drug Safety | journal | 0.428 Q3 | 41 | 63 | 136 | 2743 | 228 | 124 | 1.49 | 43.54 | |
36 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.434 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
35 | Current Nanoscience | journal | 0.453 Q2 | 52 | 135 | 296 | 4918 | 504 | 292 | 1.52 | 36.43 | |
34 | Journal of Toxicology | journal | 0.454 Q3 | 47 | 61 | 56 | 3651 | 118 | 56 | 2.11 | 59.85 | |
33 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.502 Q3 | 43 | 34 | 78 | 3271 | 168 | 78 | 1.96 | 96.21 | |
32 | Current Computer-Aided Drug Design | journal | 0.510 Q2 | 32 | 29 | 76 | 1626 | 134 | 70 | 1.80 | 56.07 | |
31 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 61 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | |
30 | Current Clinical Pharmacology | journal | 0.600 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
29 | Combinatorial Chemistry and High Throughput Screening | journal | 0.607 Q2 | 70 | 87 | 293 | 4972 | 632 | 261 | 1.99 | 57.15 | |
28 | Records of Natural Products | journal | 0.618 Q2 | 41 | 59 | 101 | 1484 | 243 | 100 | 2.33 | 25.15 | |
27 | Current Bioactive Compounds | journal | 0.660 Q1 | 31 | 46 | 80 | 2983 | 121 | 71 | 0.83 | 64.85 | |
26 | Reviews on Recent Clinical Trials | journal | 0.683 Q2 | 35 | 42 | 79 | 2507 | 186 | 79 | 2.00 | 59.69 | |
25 | Recent Patents on Drug Delivery and Formulation | journal | 0.783 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
24 | Current Neuropharmacology | journal | 0.799 Q2 | 103 | 35 | 170 | 4661 | 494 | 162 | 2.30 | 133.17 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®